ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Melatonin and oxidative DNA damage in REM- and NREM-related obstructive sleep apnea: an exploratory analysis of sleep-stage phenotypes.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeObstructive sleep apnea is associated with intermittent hypoxia and oxidative stress. Whether oxidative and antioxidant biomarkers differ between rapid eye movement-related and non-rapid eye movement-related phenotypes remains unclear. We compared circulating melatonin and oxidative stress markers across sleep-stage phenotypes and disease severity categories.
methodsIn this prospective case-control study, 165 participants (34 controls, 31 rapid eye movement-related obstructive sleep apnea, 100 non-rapid eye movement-related obstructive sleep apnea) underwent overnight polysomnography. Serum melatonin, 8-hydroxy-2'-deoxyguanosine, total oxidant status, and total antioxidant status were measured using enzyme-linked immunosorbent assay and colorimetric methods. The oxidative stress index was calculated as the ratio of total oxidant status to total antioxidant status multiplied by 100. Group comparisons were performed using nonparametric tests with appropriate post-hoc analyses. Additional analyses adjusted for age, body mass index, and sex using rank-transformed analysis of covariance. Correlations were evaluated using Spearman analysis with correction for multiple testing and formally compared between groups.
resultsIn unadjusted analyses, melatonin and 8-hydroxy-2'-deoxyguanosine levels were lower in obstructive sleep apnea, particularly in non-rapid eye movement-related and moderate disease. However, these differences were no longer statistically significant after adjustment for body mass index and sex. Total oxidant status, total antioxidant status, and oxidative stress index did not differ significantly between groups. Descriptive differences in correlation patterns were observed, but formal comparison showed no statistically significant between-phenotype differences.
conclusionCirculating redox biomarkers in obstructive sleep apnea show modest differences that appear largely influenced by body mass index and sex. These findings should be considered exploratory and hypothesis-generating rather than evidence of phenotype-specific biological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.